Skip to content

Clinical trials

Phase 4 Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 4 Country / region: United States Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20032
20041
20054
20061
20072
20081
20093
20104
20117
20121
20134
20141
20153
20164
20172
20181
20192
20201
20211
20222
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated7
Recruiting4
Unknown status3
Enrolling by invitation3
Withdrawn1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute4
Emory University3
University of Maryland, Baltimore3
University of Pennsylvania3
Duke University2
Eisai Inc.2
Indiana University2
James J. Peters Veterans Affairs Medical Center2
Massachusetts General Hospital2
Mayo Clinic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction57
Dementia11
Alzheimer Disease9
Schizophrenia6
Delirium4
Parkinson Disease4
Psychotic Disorders4
Bipolar Disorder3
Major Depressive Disorder3
Anosmia2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.